This is a Lyfgenia news story, published by CNBC, that relates primarily to Carlyle news.
For more Lyfgenia news, you can click here:
more Lyfgenia newsFor more Carlyle news, you can click here:
more Carlyle newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Bluebird shares. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest private equity firms Carlyle news, buzziest biotech firms news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Bluebird BioCNBC
•Health
Health
84% Informative
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million .
Bluebird makes three gene therapies: Zynteglo for beta thalassemia, Lyfgenia for sickle cell disease and Skysona for cerebral adrenoleukodystrophy.
The entire gene therapy field is facing tough questions about whether these treatments can become successful businesses.
The sale marks a stark reversal of Bluebird 's past performance.
VR Score
86
Informative language
86
Neutral language
54
Article tone
semi-formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links